You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)

Article metrics

Article menu
Emerging technologies, pharmacology and therapeutics
Real-world clinical outcomes following treatment intensification with GLP-1 RA, OADs or insulin in patients with type 2 diabetes on two oral agents (PATHWAY 2-OADs)

 

Online download statistics by month:

Online download statistics by month: December 2020 to March 2024

AbstractFullPdf
Dec 2020585812
Jan 2021444432196
Feb 202112912270
Mar 202110510351
Apr 2021807635
May 2021848452
Jun 2021797949
Jul 2021878344
Aug 2021625848
Sep 2021636231
Oct 2021797847
Nov 2021666549
Dec 2021757334
Jan 2022676031
Feb 2022383622
Mar 2022615823
Apr 2022555321
May 2022595731
Jun 2022403825
Jul 2022636520
Aug 2022717113
Sep 2022464621
Oct 2022519425
Nov 2022575115
Dec 2022494810
Jan 2023424013
Feb 2023434312
Mar 2023463124
Apr 2023221010
May 202319159
Jul 2023212014
Aug 202324219
Sep 202316166
Oct 2023293015
Nov 202324183
Dec 2023413810
Jan 2024232210
Feb 2024474110
Mar 2024302183
Total249524161203